Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated
ICD-10 F13.90 is a billable code used to indicate a diagnosis of sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated.
F13.90 refers to the use of sedative, hypnotic, or anxiolytic substances without any specified complications. This code is utilized when a patient exhibits signs of substance use disorder related to these classes of drugs, but without the presence of withdrawal symptoms, intoxication, or other complicating factors. Sedative-hypnotics include medications such as benzodiazepines and barbiturates, which are often prescribed for anxiety, insomnia, or other sleep disorders. Patients may develop a psychological dependence on these substances, leading to misuse or addiction. The uncomplicated nature of this code indicates that the patient does not currently exhibit severe withdrawal symptoms or acute intoxication, allowing for a focus on treatment and management strategies. Treatment may involve counseling, behavioral therapies, and monitoring for potential progression to more severe substance use disorders. Accurate coding is essential for appropriate treatment planning and insurance reimbursement.
Detailed patient history, including substance use patterns and mental health evaluations.
Patients presenting with anxiety disorders who are using sedatives without complications.
Consideration of co-occurring mental health disorders and the need for integrated treatment plans.
Comprehensive assessment of substance use, including frequency, duration, and impact on daily functioning.
Patients seeking help for sedative misuse without acute withdrawal symptoms.
Focus on harm reduction strategies and potential referrals for counseling.
Used for outpatient therapy sessions addressing sedative use.
Document the focus of therapy and any progress made.
Psychiatrists should ensure that the treatment plan aligns with the diagnosis.
F13.90 is used for uncomplicated sedative, hypnotic, or anxiolytic use, while F13.20 indicates dependence on these substances, which requires different treatment approaches and documentation.
